Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma

Published:2014-08-18 Issue:10 Volume:28 Page:1084-1091
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Pandya Chintan¹,Hashmi Shahrukh²³,Khera Nandita⁴,Gertz Morie A.²³,Dispenzieri Angela²³,Hogan William²³,Siddiqui Mustaqeem²³,Noyes Katia⁵,Kumar Shaji K.²³

Affiliation:

1. Department of Public Health Sciences; University of Rochester; Rochester NY USA

2. Transplant Center; Mayo Clinic; Rochester MN USA

3. Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester MN USA

4. Hematology Oncology/Blood and Marrow Transplant; Mayo Clinic Arizona; Phoenix AZ USA

5. Surgical Health Outcomes and Research Enterprise (SHORE); University of Rochester; Rochester NY USA

Publisher

Wiley

Subject

Transplantation

Reference34 articles.

1. Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma;Kumar;Cancer,2012

2. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial;Fermand;Blood,1998

3. Consensus Guidelines to Management of Plasma Cell Disorders Stratification for Myeloma And Risk-adapted Therapy (mSMART) http://www.msmart.org/msmart_mar09_002.htm

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm;Blood Cancer Journal;2024-08-12

2. Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?;Hematology/Oncology Clinics of North America;2023-12

3. Aiming for the cure in myeloma: Putting our best foot forward;Blood Reviews;2023-11

4. Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion;Transplantation and Cellular Therapy;2023-11

5. Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study;Cancer Biology & Medicine;2023-01-12